302 Results

People

  1. Motzer
    Motzer
  2. Kris
    Kris
  3. Drilon
    Drilon
  4. Zelenetz
    Zelenetz
  5. Gerecitano
    Gerecitano
  6. Horwitz
    Horwitz
  7. Hudis
    Hudis
  8. Miller
    Miller
  9. Moskowitz
    Moskowitz
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (210)
  2. Solid Tumor Oncology Division (127)
  3. Hematologic Malignancies, Division of (81)
  4. Center for Hematologic Malignancies (70)
  5. Genitourinary Oncology Service (39)
  6. Epidemiology and Biostatistics (37)
  7. GSK Faculty (35)
  8. Survivorship Research (34)
  9. Biostatistics Service (32)
  10. Radiology, Department of (31)
  1. "coughing"
Formats
  1. Journal Article (285)
  2. Review (7)
  3. Research Letter (5)
  4. Editorial (2)
  5. Conference Paper (1)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (210)
  2. Solid Tumor Oncology Division (127)
  3. Hematologic Malignancies, Division of (81)
  4. Center for Hematologic Malignancies (70)
  5. Genitourinary Oncology Service (39)
  6. Epidemiology and Biostatistics (37)

More Groups

People
  1. Robert Motzer (22)
  2. Mark Kris (12)
  3. Alexander Drilon (9)
  4. Andrew Zelenetz (9)
  5. Clifford Hudis (8)
  6. John Gerecitano (8)

More People

Years
  1. 2025 (9)
  2. 2024 (24)
  3. 2023 (25)
  4. 2022 (18)
  5. 2021 (14)
  6. 2020 (30)

More Years

Publications
  1. Lancet Oncology (23)
  2. Clinical Cancer Research (22)
  3. Journal of Clinical Oncology (16)
  4. New England Journal of Medicine (15)
  5. Blood (13)
  6. Cancer (13)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. Elsevier Science, Inc. (37)
  3. American Association for Cancer Research (23)
  4. Nature Publishing Group (21)
  5. Wiley Blackwell (18)
  6. American Society of Clinical Oncology (17)

More Publishers

Results (302)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Eprenetapopt plus azacitidine after allogeneic hematopoietic stem-cell transplantation for TP53 -mutant acute myeloid leukemia and myelodysplastic syndromes
    Journal Article

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Sallman, D.; Gallacher, P.; Wennborg, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer
    Journal Article

    Van Cutsem, E.; Hochster, H.; Shitara, K.; Mayer, R.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H. T.; more...
    ESMO Open (2022)

    Fulltext@MSK | Save
  • Ibrutinib treatment of pediatric chronic graft-versus-host disease: Primary results from the phase 1/2 iMAGINE study
    Journal Article

    Carpenter, P. A.; Kang, H. J.; Yoo, K. H.; Zecca, M.; Cho, B.; Lucchini, G.; Nemecek, E. R.; Schultz, K. R.; Stepensky, P.; Chaudhury, S.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab with obinutuzumab and bendamustine in previously untreated follicular lymphoma
    Journal Article

    Younes, A.; Burke, J. M.; Diefenbach, C.; Ferrari, S.; Khan, C.; Sharman, J. P.; Tani, M.; Ujjani, C.; Vitolo, U.; Yuen, S.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Development of an easily reproducible cough simulator with droplets and aerosols for rapidly testing novel personal protective equipment
    Journal Article

    Zhou, G.; Burnett, G. W.; Shah, R. S.; Lai, C. Y.; Katz, D.; Fried, E. A.
    Simulation in Healthcare (2022)

    Fulltext@MSK | Save
  • The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study: Symptoms, toxicity and quality of life of lung cancer patients
    Journal Article

    van der Weijst, L.; Azria, D.; Berkovic, P.; Boisselier, P.; Briers, E.; Bultijnck, R.; Chang-Claude, J.; Choudhury, A.; Defraene, G.; Demontois, S.; more...
    Radiotherapy and Oncology (2022)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis
    Journal Article

    Cadoo, K.; Simpkins, F.; Mathews, C.; Liu, Y. L.; Provencher, D.; McCormick, C.; ElNaggar, A. C.; Altman, A. D.; Gilbert, L.; Black, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
    Journal Article

    Choi, J. I.; Prabhu, K.; Hartsell, W. F.; DeWees, T.; Sinesi, C.; Vargas, C.; Benda, R. K.; Cahlon, O.; Chang, A. L.
    Clinical and Translational Radiation Oncology (2022)

    Fulltext@MSK | Save
  • First-in-human phase I study of the OX40 agonist MOXR0916 in patients with advanced solid tumors
    Journal Article

    Kim, T. W.; Burris, H. A. 3rd; de Miguel Luken, M. J.; Pishvaian, M. J.; Bang, Y. J.; Gordon, M.; Awada, A.; Camidge, D. R.; Hodi, F. S.; McArthur, G. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save